epilepsy, mTORopathies, focal cortical dysplasia, LEATS

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Open-label study to assess safety and efficacy of rapamycin in drugresistant epilepsy associated with mTOR pathway pathologies Ended

2024-515950-25-00 4 2023-06-27

Showing 1–1 of 1 trials